News | Treatment Planning | November 24, 2015

RaySearch, CERN and INFN Sign Ion Beam Therapy License Agreement

Deal allows RaySearch to incorporate FLUKA algorithm into RayStation treatment planning system for ion beam therapy

November 24, 2015 — CERN, INFN and RaySearch Laboratories AB signed a long-term license agreement in September allowing RaySearch to utilize the FLUKA Monte Carlo code in its research and development in the field of ion beam therapy.

FLUKA is a general purpose tool for calculations of particle transport and interactions with matter, covering an extended range of applications spanning from proton and electron accelerator shielding to target design, calorimetry, activation, dosimetry, detector design, accelerator-driven systems, cosmic rays, neutrino physics and radiation therapy. The FLUKA code has been developed and is maintained by CERN and INFN and represents state-of-the-art in terms of simulation accuracy in areas where hadron interaction physics play an important role.

At RaySearch, the FLUKA code will be an essential tool for research and development in the field of ion beam therapy, which is the most advanced form of external radiation therapy where the tumor is irradiated using, for example, carbon ion beams. Compared to conventional radiation therapy, where the tumor is irradiated using photons, the energy deposition of the ion beams can be controlled more effectively. This means the radiation dose can be delivered even more precisely and, as a result, the unwanted dose to healthy tissues can be reduced, leading to a reduction in treatment-related side effects. In addition, radiation therapy with carbon ions can be used to target tumors with low levels of oxygen, so called hypoxic tumors, for which conventional radiation therapy has limited effect.

By the license agreement concluded, RaySearch is entitled to integrate data generated by the FLUKA code into algorithms of RaySearch’s treatment planning system, RayStation. Ongoing development will comprise a new module for carbon ion treatment optimization, where FLUKA results will be input to pencil beam and Monte Carlo dose engines, and into computations of relative biological effectiveness. The new module will be included in version 5 of RayStation, to be released in December 2015. MedAustron in Wiener Neustadt in Austria and Centro Nazionale di Adroterapia Oncologica (CNAO) in Pavia, Italy, will be the first centers to use RayStation clinically for carbon ion treatment planning.

For more information: www.raysearchlabs.com

Related Content

Sponsored Content | Videos | Radiation Therapy | January 18, 2019
Join Chris Toth, president of Varian’s Oncology Systems business, for a look at product introductions for 2018 plus
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.